S P Apparels Ltd.: Q2FY18 Result Update

Similar documents
S.P.Apparels Ltd. Q1FY18 Result Update

Trident Ltd: Q2FY18 Result Update

Trident Ltd.: Q1FY18 Result Update

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

PNC Infratech Ltd.: Q3FY18 Result Update

Dilip Buildcon Ltd.: Q3FY18 Result Update

Zee Learn Ltd.: Q2FY18 Result Update

RELIANCE INDUSTRIES LIMITED

Economic Spotlight. Current Account Deficit Narrows. Edelweiss Investment Research

Economic Spotlight. Revised Govt. Borrowing Means More Fiscal Room. Edelweiss Investment Research

Ratnamani Metals & Tubes Ltd.: Q1FY18 Results Update

Transformer and Rectifier (India) Ltd: Q4FY17 Result Update

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

Kirloskar Brothers Ltd.: Q1FY18 Result Update

Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH

First Flash: Butterfly Gandhimathi Appliances Ltd

Performance Tracker Equity

Kirloskar Brothers Ltd.: Q4FY17 Result Update

Edelweiss Investment Research Stock view: Axis Bank Ltd. Axis Bank Ltd.

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Cummins India Ltd Bloomberg Code: KKC IN

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Gillette India. Institutional Equities. 1QFY18 Result Update

Near-term pressure, but long-term outlook positive

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Jamna Auto Industries

Institutional Equities

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Visaka Industries Ltd

Fineotex Chemical Ltd

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Change EPS. (Rs) FY

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Colgate-Palmolive (India)

Adani Ports & SEZ Rating: Target price: EPS:

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Amber Enterprises India Ltd

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Indo Count Industries BUY

Key estimate revision. Financial summary. Year

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Dr Reddy s Laboratories

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Hold Target Price: Rs 574

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Indian Oil Corporation

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Initiating Coverage. Uflex Ltd.

HINDUSTAN UNILEVER Indulekha allure for the tresses

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

ITC Ltd. RESULT UPDATE 27th October, 2017

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Symphony Ltd. RESULT UPDATE 31st October 2017

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Century Plyboards (India)

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Century Plyboards (India)

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

Britannia Industries Ltd.

Colgate-Palmolive India Ltd.

TTK Prestige. Channel-check takeaways Growth recovery pace sees moderation, competitive headwinds continue to prevail. Target CMP. Rating Rs.

City Union Bank BUY. 24 February 2016 INR82

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Tech Mahindra. 1QFY18 Result Update. Steps in the right direction, compelling valuation. Sector: Technology CMP: ` 385. Recommendation: Buy

Ahluwalia Contracts (India)

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Simplex Infrastructures

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

Transcription:

Edelweiss Investment Research S P Apparels Ltd.: Q2FY18 Result Update Brexit impacts another quarter; Worst is behind CMP INR 367 Target INR 500 Rating: BUY Upside: 37% Date: 16 th November 2017 Inspite of multiple headwinds such as Brexit, currency volatility, adverse raw material prices, GST and downward revision of duty drawback rates, S.P.Apparels Ltd. (SPAL) still reported flat revenues at INR 170cr. While most textile players have reported a fall in margins owing to multiple headwinds, SPAL reported an improved adjusted EBITDA margin from 17.6% in Q2FY17 to 18.6% in Q2FY18. Reported PAT at INR 10 Cr was lower than Q2FY17 PAT of INR 15 Cr due to MTM forex losses and higher finance cost (one-off as preference dividend is now included in finance cost as per new accounting standards). The domestic retail brand Crocodile reported a 33% revenue growth but more importantly has broken even in this quarter with 6.3% EBITDA margins. Owing to Brexit, we feel that SPAL has refrained from taking lower margin orders resulting in a flat topline versus our expectation of a 10% growth in H1FY18. Taking this into consideration and lower duty drawback rates, we cut our FY18E revenues by 7% and EBITDA estimates by 11% and arrive at a revised target price of INR 500 (earlier INR 550). Garments division results in line with guidance inspite of multiple headwinds; New client shipments underway H1FY18 witnessed Brexit pressures, as subdued growth on account of Brexit, led many clients to take price cuts which would have resulted in lower margins for SPAL. However SPAL refrained from taking certain orders to protect their margin which is a prudent strategy as H2FY18 has already resulted in a better enviornment and SPAL has been able to restart orders from the older clients. SPAL has also started shipments to its 3 new clients which should aid topline from the next quarter. The capex plans are on track with the beginning of construction of the spinning facility. The completion of this facility will lead to backward integration and improve EBITDA margins in FY19E. Crocodile turns around The domestic retail brand Crocodile delivered a 33% YoY growth and has finally turned around with EBITDA margins of 6.3% in Q2FY18 vs. Negative 6.3% in Q2FY17. This was led by a change in strategy as highlighted in Q1FY18 where the company changed their distribution strategy by expanding through the Large Format Stores (LFS) rather than through EBOs. Post closing down loss making EBOs, SPAL has 35 COCO stores, 12 FOFO stores and presence in 180 LFS (140 in Q1FY18). They have plans to convert existing COCO stores into FOFO stores and to have a presence in 300 LFS by FY19E. Outlook and valuations: Attractive; Re-iterate Strong BUY Although we maintain our FY19E topline growth estimates and margins, our downward revision of FY18E numbers has resulted in a 10% cut in our FY19 EPS. We still recommend a BUY with a revised target price of INR 500 (earlier INR 550) valuing SPAL at 13x FY19E P/E. (INR cr) Q2FY18 Q2FY17 % change Q1FY18 % change FY17 FY18E FY19E Income from operations 170 172-1% 151 13% 652 719 869 Growth % 21 10 21 Total operating expenses 138 143-3% 128 8% 530 586 695 EBITDA 32 29 10% 28 14% 122 133 174 Adjusted net profit 10 15-37% 11-14% 63 72 101 Growth % 75 15 41 Diluted P/E (x) 11.7 12.3 8.8 RoACE (%) 19.4 17.4 21.6 EV/EBITDA (x) 8.2 6.8 4.8 Bloomberg: SPAL:IN 52-week range (INR): 484 / 276 Share in issue (cr): 2 M cap (INR cr): 947 Avg. Daily Vol. BSE/NSE :( 000): 5 Promoter Holding (%) 60.2 1 GWM/Edelweiss Investment Research Kshitij Kaji Research Analyst Kshitij.kaji@edelweissfin.com Praveen Sahay Research Analyst Praveen.sahay@edelweissfin.com

S P Apparels Ltd. Q2FY18 Result Highlights Particulars (INR cr) Q2FY18 Q2FY17 % change Q1FY18 % change FY17 FY18E FY19E Revenues 166 167-1% 151 10% 652 719 869 Gain from forex fluctuation 4 5-20% 5-20% 18 NA NA Total revenues 170 172-1% 156 9% 670 719 869 COGS 68 71-4% 59 15% 254 284 336 Gross Profit 102 101 1% 97 5% 400 435 534 Employee Expenses 33 38-13% 38-13% 147 164 199 Total expenses 70 72-3% 69 1% 277 302 360 EBITDA 32 29 10% 28 14% 123 133 174 Depreciation 6 5 20% 5 20% 20 25 27 EBIT 26 24 8% 23 13% 103 108 147 Interest expenses 8 3 167% 7 14% 14 10 8 Other income 1 1 NA 5 NA 4 9 10 MTM Forex loss/exceptional 4 0 NA 4 0% -2 NA NA PBT 15 22-34% 17-15% 94 107 149 Provision for tax 5 7-29% 6-17% 33 36 49 PAT 10 15-37% 11-14% 61 71 100 2 GWM/Edelweiss Investment Research

S P Apparels Ltd. About the Company S.P. Apparels (SPAL) is India s leading manufacturer and exporter of infants & children s garments (knitwear segment) in the 0-8 years category to UK s marquee retailers Tesco, Primark, ASDA, Mothercare and Dunnes. Although the company s growth has been subdued over the past 5 years, the recent balance sheet clean up has set the stage for aggressive surge, apparent in the 33% top line spurt in H1FY17. Incremental orders from fast growing clients and expansion to new geographies (US) are envisaged to yield sustained 18-20% top-line growth. Moreover, higher backward integration and tailwinds from government incentives for textile exporters are anticipated to spur SPAL s operating margin. We are convinced that burgeoning order book, entry in new export markets, and a lean balance sheet are key ingredients that will enable SPAL spin a commendable growth story. Investment Theme Niche capability and strong ties with marquee global retailers SPAL is a differentiated childrenswear exporter as it manufactures design-specific medium-sized orders of 20,000-50,000 pieces as opposed to competitors, which manufacture simple bulk orders of 1,00,000 plus pieces. The company s USP is that it is actively involved in design development as its core competency lies in understanding latest fashion trends to suit customer s preferences. Ergo, its realisations are almost 3x competitors. Also, SPAL has proven its ability to adhere to highest standards of safety and quality norms which are mandatory for childrenswear. This niche has helped the company establish its credentials and forge longterm alliances with UK s marquee retailers. Revitalised balance sheet to spur garments division; Crocodile s expansion to spruce up domestic revenue A high debt to equity of 5.0x in FY12 and 2.2x in FY16 offered SPAL very little room to pursue aggressive growth despite burgeoning interest from potential clients. Exotic currency hedging options of INR8cr were rolled over on the advice of banks, leading to a ballooning payment obligation and a final settlement at INR85cr, which sapped the balance sheet. However, debt, which stood at INR392cr in FY12, has dipped to INR175cr and the debt to equity has plummeted significantly to 0.4x currently. Hence, we estimate SPAL s garment division to post 15-20% CAGR over FY16-19 versus 7.4% CAGR over FY12-16 due to higher financial freedom. Moreover, we envisage Primark to spearhead surge and growth can be further accentuated by adding 1-2 more customers from non-uk regions. Expansion of the retail brand Crocodile in the domestic market is also bound to spur growth (currently domestic revenue constitutes mere 10% of total). Backward integration and deleveraging exercise potent bottom-line boosters SPAL has chalked out a comprehensive plan to utilise INR215cr of IPO proceeds to complete the backward integration process and prune debt. The backward integration plan to change the count of spinning capacity to suit its needs coupled with a new knitting facility and balancing of dyeing facility will help the company be full vertically integrated. This will boost EBITDA margin by at least 200bps. Additionally, debt repayment of close to INR75cr will provide a further leg up to the bottom line, which is estimated to clock 46% CAGR over FY16-19. Key Risks Customer and geographic concentration risk alongwith risk of stagnating customer growth Changes in domestic and international regulations and other events such as Brexit Increasing competition from other unorganized and international players Long term profitable growth in the retail division remains unclear 3 GWM/Edelweiss Investment Research

S P Apparels Ltd. Financials Income statement (INR Cr) Income from operations 473 537 652 719 869 Direct costs 225 224 273 284 336 Employee costs 100 121 149 164 199 Other expenses 179 228 257 302 360 Total operating expenses 404 452 530 586 695 Adjusted EBITDA 69 85 122 133 174 Depreciation and amortisation 20 20 21 25 27 EBIT 49 65 101 108 147 Interest expenses 31 25 13 10 8 Other income/ MTM Loss 7 5 6 9 10 Profit before tax 24 45 94 107 149 Provision for tax 15 9 32 36 49 Core profit 10 35 62 71 100 Extraordinary items 0-16 0 0 0 Profit after tax 10 19 62 71 100 Minority Interest 0 0 1 1 1 Share from associates 0 0 0 0 0 Adjusted net profit 10 19 63 72 101 Equity shares outstanding (mn) 2 2 2 2 2 EPS (INR) basic 6.0 20.6 31.2 29.9 41.9 Diluted shares (Cr) 1.7 1.7 2.4 2.4 2.4 EPS (INR) fully diluted 6.0 20.6 31.2 29.9 41.9 Dividend per share 0.0 0.0 0.0 0.0 0.0 Dividend payout (%) 0.0 0.0 0.0 0.0 0.0 Common size metrics- as % of net revenues Operating expenses 85.4 84.2 81.3 81.6 80.0 Depreciation 4.2 3.7 3.2 3.5 3.1 Interest expenditure 6.6 4.7 2.1 1.4 0.9 Adjusted EBITDA margins 14.6 15.8 18.7 18.4 20.0 Net profit margins 2.1 3.6 9.7 10.0 11.6 Growth metrics (%) Revenues 4.8 13.6 21.4 10.3 20.9 EBITDA 7.9 23.2 43.7 8.7 31.4 PBT 106.0 82.2 110.5 13.8 39.9 Net profit 50.1 263.4 75.5 14.9 41.0 EPS 50.9 244.9 51.9 (4.4) 40.2 Balance sheet (INR cr) As on 31st March FY15 FY16 FY17 FY18E FY19E Equity share capital 17 17 24 24 24 Preference Share Capital 27 20 21 21 21 Reserves & surplus 59 96 358 430 531 Shareholders funds 103 133 403 475 576 Secured loans 216 230 151 80 50 Unsecured loans 60 59 0 59 59 Borrowings 276 288 151 130 100 Minority interest -5-6 0 0 0 Sources of funds 374 415 554 605 676 Gross block 417 436 478 528 553 Depreciation 141 159 180 205 232 Net block 275 277 298 323 321 Capital work in progress 0 4 0 0 0 Total fixed assets 275 281 298 323 321 Unrealised profit 0 0 0 0 0 Investments 1 1 66 5 5 Inventories 107 128 102 164 193 Sundry debtors 74 82 135 109 132 Cash and equivalents 7 11 35 117 152 Loans and advances 32 31 57 63 76 Other current assets 0 0 0 0 0 Total current assets 220 251 330 453 553 Sundry creditors and others 103 95 93 127 153 Provisions 9 10 9 9 10 Total CL & provisions 112 105 101 136 163 Net current assets 108 146 228 317 390 Net Deferred tax -32-37 -40-40 -40 Misc expenditure 22 25 1 0 0 Uses of funds 374 415 554 605 676 Book value per share (INR) 61 77 167 197 238 Cash flow statement Net profit 10 26 76 71 100 Add: Depreciation 20 20 21 25 27 Add: Misc expenses written off -6-3 24 1 0 Add: Deferred tax 14 6 3 0 0 Add: Others 0 0 1 1 1 Gross cash flow 39 48 125 99 128 Less: Changes in W. C. -21 34 58 7 39 Operating cash flow 60 14 66 92 90 Less: Capex 11 25 38 50 25 Free cash flow 49-11 28 42 65 Ratios ROAE (%) 14.0 37.4 31.0 17.3 20.1 ROACE (%) 11.6 15.1 19.4 17.4 21.6 Debtors (days) 57 55 55 55 55 Current ratio 2.0 2.4 3.3 3.3 3.4 Debt/Equity 2.7 2.2 0.4 0.3 0.2 Inventory (days) 83 87 85 83 81 Payable (days) 80 64 64 64 64 Cash conversion cycle (days) 60 78 76 74 72 Debt/EBITDA 4.0 3.4 1.2 1.0 0.6 Adjusted debt/equity 2.6 2.1 0.3 0.0 (0.1) Valuation parameters Diluted EPS (INR) 6.0 20.6 31.2 29.9 41.9 Y-o-Y growth (%) 50.9 244.9 51.9 (4.4) 40.2 CEPS (INR) 17.8 32.3 40.3 40.3 53.1 Diluted P/E (x) 61.5 17.8 11.7 12.3 8.8 Price/BV(x) 6.0 4.7 2.2 1.9 1.5 EV/Sales (x) 1.9 1.7 1.5 1.3 1.0 EV/EBITDA (x) 12.9 10.7 8.2 6.8 4.8 Diluted shares O/S 1.7 1.7 2.4 2.4 2.4 Basic EPS 6.0 20.6 31.2 29.9 41.9 Basic PE (x) 61.5 17.8 11.7 12.3 8.8 Dividend yield (%) 0.0 0.0 0.0 0.0 0.0 4 GWM/Edelweiss Investment Research

Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 (Indexed) S P Apparels Ltd. Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period 170 150 130 110 90 70 50 SP Apparels Sensex 5 GWM/Edelweiss Investment Research

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Brijmohan Bohra, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. 18001023335/022-42722200/022-40094279 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. 6 GWM/Edelweiss Investment Research

Disclaimer Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. 7 GWM/Edelweiss Investment Research

Disclaimer Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 8 GWM/Edelweiss Investment Research